Brian Ennis Appointed President of Empi, Inc. and Compex Technologies, Inc., Subsidiaries of Encore Medical Corporation

AUSTIN, Texas, March 7  /PRNewswire-FirstCall/ -- Brian T. Ennis has been appointed President of Encore Medical Corporation's (NASDAQ:ENMC) subsidiaries, Empi, Inc. and the recently acquired Compex Technologies, Inc., effective immediately, it was announced today by Paul Chapman, President and Chief Operating Officer of Encore Medical.

In his new assignment, Mr. Ennis will be responsible for leading the combination of the two companies and building the Encore home orthopedic rehabilitation platform.  The acquisition of Compex was completed by Encore in late February and a key initiative for Encore is bringing together these two organizations in a manner that builds sales while achieving greater operating income through exploiting synergies and operating leverage.  Mr. Ennis will be at the forefront of these efforts, leading a combined workforce of approximately 1,100, which includes the direct sales forces of each organization.

Commenting on the announcement, Mr. Chapman said, "A key element of Encore's ongoing success will be our ability to bring together the Empi and Compex organizations and grow our Orthopedic Rehabilitation Division revenues, increase our margins, and build our profits. Under Brian's able leadership, we are confident that he can harness the efforts of all of the capable and hard working Compex and Empi employees to build towards these goals."

Mr. Ennis brings with him significant experience in the orthopedic area, having worked at Stryker Corporation from 1989 to 2000, in both their domestic and international marketing and management areas, as well as most recently holding the position of President of International at Wright Medical Group from 2001 to 2005.  In both of those companies, he demonstrated an ability to grow revenues and build organizations.

Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries.  Through its Orthopedic Rehabilitation Division, Encore is a leading distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants.  For more information, visit http://www.encoremed.com/ .

   Contact  Davis Henley, Vice President - Business Development
            [phone]
            



Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  These statements involve risks and uncertainties, such as fluctuations in operating results, the timely availability of new products, the impacts of competitive products and pricing, the effects of integration efforts, including retaining customers and employees, the ability to grow and integrate the distribution networks for the Company's products, the ability to continue to obtain long- term financing, and the ability to locate and integrate future acquisitions and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission.  These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. 

DATASOURCE: Encore Medical Corporation



CONTACT:  Davis Henley, Vice President - Business Development of Encore

Medical Corporation, [phone], or  



Web site:  http://www.encoremed.com/ 

Copyright